Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The main purpose is to determine the safety of Triferic iron administered via dialysate and
intravenously in pediatric patients with chronic kidney disease on chronic hemodialysis
(CKD-5HD). It is a global, multi- center, open-label study.